CDK1 and Hyperinsulinemia: It has been reported that hepatocyte-specific knockout of CDK1 reduces hepatic triglyceride (TG) levels, but simultaneously impairs fatty acid oxidation (FAO) in hepatocytes, leading to excessive free fatty acids (FFA) that promote hyperinsulinemia [35].